COMMUNIQUÉS West-GlobeNewswire

Qinotto and Lilly Enter Research Collaboration and License Agreement

08/10/2024 - 18:00

Combination of Qinotto’s novel blood brain barrier platform and Lilly's therapeutic expertise could boost the delivery of large molecule therapeutics to the brain SAN CARLOS, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- [...]

Scilex Holding Company Announces Closing of a $50 Million Registered Convertible Financing

08/10/2024 - 17:50

PALO ALTO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

EchoNous Partners with Mendaera to Revolutionize Image-Guided Intervention

08/10/2024 - 17:36

REDMOND, Wash. and SAN MATEO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- EchoNous, a pioneer in portable ultrasound technology, has announced a commercial partnership with Mendaera, a Silicon Valley-based healthcare [...]

From Ideation to Commercialization: Nutrify Today’s NutrifyGenie Exceeds AI Expectations

08/10/2024 - 16:26

BANGALORE, India, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nutrify Today ’s AI platform, NutrifyGenie , is redefining the nutraceutical industry by taking product concepts from idea to full-scale commercialization. By [...]

ARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and Workforces

08/10/2024 - 16:11

CUPERTINO, Calif. and MELBOURNE, Australia, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their [...]

Curia dévoile une marque plus moderne à l'occasion du salon de la CPHI Worldwide qui se tient à Milan

08/10/2024 - 16:02

La marque sophistiquée met en valeur les principales capacités de Curia et son approche personnalisée en matière de petites molécules, d’IPA génériques et de produits biologiques ALBANY, New York, 08 oct. 2024 (GLOBE [...]

Sevaro Partners with Rosman Search to Elevate Neurology Services in Hospitals Nationwide

08/10/2024 - 16:00

EAST BRUNSWICK, N.J., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Sevaro, a leading provider of virtual neurology technology platforms and teleneurology services , proudly announces a strategic partnership with Rosman Search. [...]

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

08/10/2024 - 16:00

The unique assay enables laboratories to provide clinicians with more informed treatment decisions for their patients NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]

Growth.Health Announces Launch of Powerful Data & Analytics Platform

08/10/2024 - 15:02

G1 Platform Proves Unsurpassed Customer and Prospect Insights Via Privacy Preserving Records Linkage and Marketing Operationalization ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Growth.Health today announced the launch [...]

E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment

08/10/2024 - 15:00

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced [...]

Toronto Maple Leafs' Mitch Marner, London Health Sciences Foundation, partner to launch $50,000 “Marner Match” for Youth Mental Health

08/10/2024 - 15:00

LONDON, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- London Health Sciences Foundation (LHSF) is teaming up with Mitch Marner of the Toronto Maple Leafs and the Marner Assist Foundation to make a game-changing difference [...]

Curia Commits to SBTi Net-Zero Standard

08/10/2024 - 15:00

ALBANY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced its commitment to set near- and long-term company-wide greenhouse gas (GHG [...]

Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors

08/10/2024 - 15:00

Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination with Merck’s anti- [...]

Privia Health to Report Third Quarter 2024 Results on Thursday, November 7

08/10/2024 - 15:00

ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, [...]

Doheny Eye Institute Announces Upcoming Presentations at American Academy of Ophthalmology 2024 Annual Meeting

08/10/2024 - 15:00

Doheny ophthalmologists selected to give more than 20 presentations and talks PASADENA, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, [...]

WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications

08/10/2024 - 15:00

The new offering, starting at $129, enhances the Company’s holistic weight management program, which includes behavioral and clinical solutions with support from board-certified clinicians, registered dietitians, and [...]

Avalyn CEO Lyn Baranowski Named a PharmaVoice 100 Honoree

08/10/2024 - 15:00

CAMBRIDGE, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, [...]

T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

08/10/2024 - 15:00

Pioneering a new frontier in antibiotic stewardship to combat the growing threat of antimicrobial resistance LEXINGTON, Mass. and SCHENECTADY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), [...]

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA

08/10/2024 - 14:55

TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]